FDA Nod For AZN's Asthma Drug, Genmab Revises Outlook, NBY Disappoints

Today's Daily Dose brings you news about Apollo Medical's fiscal 2018 second quarter financial results; FDA approval of AstraZeneca's asthma drug; EyeGate's upcoming clinical trial catalysts; Genmab's revised revenue outlook and Pacira's update on its EXPAREL sNDA.

from RTT - Biotech http://ift.tt/2zHnMdN
via IFTTT